In vitro activity of Gemifloxacin against contemporary clinical bacterial isolates from eleven North American medical centers, and assessment of disk diffusion test interpretive criteria
- 1 December 2000
- journal article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 38 (4) , 243-253
- https://doi.org/10.1016/s0732-8893(00)00198-x
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- In Vitro Susceptibilities of 400 Spanish Isolates of Neisseria gonorrhoeae to Gemifloxacin and 11 Other Antimicrobial AgentsAntimicrobial Agents and Chemotherapy, 2000
- Antimicrobial activity of advanced-spectrum fluoroquinolones tested against more than 2000 contemporary bacterial isolates of species causing community-acquired respiratory tract infections in the United States (1999)Diagnostic Microbiology and Infectious Disease, 2000
- Pharmacokinetics and Tolerability of Gemifloxacin (SB-265805) after Administration of Single Oral Doses to Healthy VolunteersAntimicrobial Agents and Chemotherapy, 2000
- Activities and Postantibiotic Effects of Gemifloxacin Compared to Those of 11 Other Agents against Haemophilus influenzae and Moraxella catarrhalisAntimicrobial Agents and Chemotherapy, 2000
- Comparative In Vitro Activities of Ciprofloxacin, Gemifloxacin, Grepafloxacin, Moxifloxacin, Ofloxacin, Sparfloxacin, Trovafloxacin, and Other Antimicrobial Agents against Bloodstream Isolates of Gram-Positive CocciAntimicrobial Agents and Chemotherapy, 2000
- Antipneumococcal Activities of Gemifloxacin Compared to Those of Nine Other AgentsAntimicrobial Agents and Chemotherapy, 2000
- Activity of Gemifloxacin against Penicillin- and Ciprofloxacin-Resistant Streptococcus pneumoniae Displaying Topoisomerase- and Efflux-Mediated Resistance MechanismsAntimicrobial Agents and Chemotherapy, 1999
- In Vitro Activity of Gemifloxacin (SB 265805) against AnaerobesAntimicrobial Agents and Chemotherapy, 1999
- Anti-streptococcal activity of SB-265805 (LB20304), a novel fluoronaphthyridone, compared with five other compounds, including quality control guidelinesDiagnostic Microbiology and Infectious Disease, 1999
- International multicenter investigation of LB203W. a new fluoronaphthyridoneClinical Microbiology & Infection, 1998